Skip to content

13F-HR filed by Sanofi

Sanofi filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-07-28, with 10 holding rows worth $534,041,662.

Accession
0001193125-26-318812
Filed
2026-07-28
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2026

A holdings report, 10 entries on the cover page, a total value of $534,041,662 stated on the cover page (in dollars after the unit check, H1), rows summing to $534,041,662 with VALUE read as dollars as filed, 13F file number 028-25202. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
MEIRAGTX HOLDINGS PLCG59665102COMMON STOCK12,197,737$164,791,427dollars as filed
INHIBRX BIOSCIENCES INC45720N103COM1,157,926$109,713,489dollars as filed
NOVAVAX INC670002401COM NEW6,880,481$64,814,131dollars as filed
ANAPTYSBIO INC032724106COM821,917$55,479,398dollars as filed
Odyssey Therapeutics, Inc.67613T104COMMON STOCK1,991,918$37,268,786dollars as filed
AGOMAB THERAPEUTICS NV00860C102SPONSORED ADS2,783,096$36,124,586dollars as filed
MAPLIGHT THERAPEUTICS INC56565P103COMMON STOCK912,041$32,687,549dollars as filed
FIRST TRACKS BIOTHERAPEUTICS337185102ORD SHS *A*821,917$16,536,970dollars as filed
IMMUNEERING CORP45254E107CLASS A COM2,708,559$13,515,709dollars as filed
Q32 BIO INC746964105Common Stock244,083$3,109,617dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001193125-26-318812this filing2026-07-28acceptance time not in the bulk data set